Pereyra-Talamantes A, Flores-Martín JE, Gallaga-Rojas MA, Rodríguez-Silverio JE, González-Azua E, Alonso-Calamaco ME, Jiménez-Chavarría E, Noyola-Villalobos HF

Language: Spanish
References: 17
Page: 41-45
PDF size: 241.61 Kb.

ABSTRACT

Introduction: intra-pancreatic accessory spleen (IPAS) is a benign condition difficult to differentiate from non-functioning pancreatic neuroendocrine tumors (Nf-PNET). Failure to differentiate between them at approach mandates surgery. Case presentation: a 46-year-old patient with chronic abdominal pain and a 1.9 cm pancreatic tumor at the pancreatic tail found by tomography, who underwent robot-assisted pancreatic tail resection successfully. There were no complications; no exocrine or endocrine insufficiency reported at 1-year. IPAS was diagnosed by the pathologist. Conclusions: this case describes the diagnostic and therapeutic approach of a very rare pathology like the intrapancreatic accessory spleen. Failure to differentiate a IPAS from a Nf-PNET through imaging studies is indicative of surgical treatment to avoid progression of malignant tumors.

REFERENCES

1. Renno A, Hill M, Abdel-Aziz Y et al Diagnosis of intrapancreatic accessory spleen by endoscopic ultrasound-guided fine-needle aspiration mimicking a pancreatic neoplasm: a case report and review of literature. Clin J Gastroenterol. 2020; 13: 287-297. doi: 10.1007/s12328-019-01045-y.

2. Bhutiani N, Egger ME, Doughtie CA et al. Intrapancreatic accessory spleen (IPAS): a single-institution experience and review of the literature. Am J Surg. 2017; 213: 816-820.

3. Halpert B, Gyorkey F. Lesions observed in accessory spleens of 311 patients. Am J Clin Pathol. 1959; 32: 165-168.

4. Arkadopoulos N, Athanasopoulos P, Stafyla V et al. Intrapancreatic accessory spleen issues: diagnostic and therapeutic challenges. JOP. 2009; 10: 400-405.

5. Massironi S, Sciola V, Peracchi M et al. Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol. 2008; 14: 5377-5384.

6. Ehehalt F, Saeger HD, Schmidt CM Neuroendocrine tumors of the pancreas. Oncologist. 2009; 14: 456-467.

7. Ro C, Chai W, Yu VE, Yu R. Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment. Chin J Cancer. 2013; 32: 312-324.

8. Guo W, Han W, Liu J et al. Intrapancreatic accessory spleen: a case report and review of literature. World J Gastroenterol. 2009; 15: 1141-1143.

9. Falconi M, Eriksson B, Kaltsas G et al. Consensus guidelines for the management of functional p-NETs (F-p-NETs) and non-functional p-NETs (NF-p-NETs). Neuroendocrinology. 2016; 103: 153-171.

10. Partelli S, Maurizi A, Tamburrino D et al. Surgical management of pancreatic neuroendocrine neoplasms. Ann Saudi Med. 2014; 34: 1-5.

11. Büchler MW, Wagner M, Schmied BM et al. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg. 2003; 138: 1310-1314.

12. Yeo CJ, Cameron JL, Sohn TA et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications and outcomes. Ann Surg. 1997; 226: 248-257.

13. Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg. 2015; 220: 530-536. Available in: https://doi.org/10.1016/j.jamcollsurg.2014.12.031

14. Smith JK, Ng SC, Hill JS et al. Complications after pancreatectomy for neuroendocrine tumors: a national study. J Surg Res. 2010; 163: 63-68.

15. Kunz PL, Reidy-Lagunes D, Anthony LB, Bertino EM, Brendtro JA. Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas. 2013; 42: 557-567.

16. Singh S, Dey C, Kennecke H et al. Consensus recommendations for the diagnosis and management of pancreatic neuroendocrine tumors: guidelines from a Canadian national expert group. Ann Surg Oncol. 2015; 22: 2685-2699.

17. Nakai Y, Takahara N, Mizuno S, Kogure H, Koike K. Current status of endoscopic ultrasound techniques for pancreatic neoplasms. Clin Endosc. 2019; 52: 527-532.